Visualitza per autor "Prager, M.D., Gerald"
Ara mostrant els elements 1-1 d 1
-
Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial
Fakih, Marwan; Prager, M.D., Gerald; Van Cutsem, Eric; Tabernero, Josep; taieb, julien; Ciardiello, Fortunato (Elsevier, 2024-03)